Figure 2

The treatment group presented a more robust decrease in metabolic indicators such as homeostasis model assessment of insulin resistance (a), glycosylated hemoglobin (b), fasting blood glucose (c), body mass index (d) and triglyceride (e) compared with the control group. * p < 0.05; HOMA-IR = homeostasis model assessment of insulin resistance, HbA1c glycosylated haemoglobin, FBG fasting blood glucose, BMI body mass index, TG triglyceride.